Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Seda Yılmaz & Pınar Öner. (2023) Melatonin levels are low in COVID-19 positive patients and these levels are associated with depression, death anxiety and insomnia. Scandinavian Journal of Clinical and Laboratory Investigation 83:2, pages 86-94.
Read now
Read now
Silvia Rivara, Daniele Pala, Annalida Bedini & Gilberto Spadoni. (2015) Therapeutic uses of melatonin and melatonin derivatives: a patent review (2012 – 2014). Expert Opinion on Therapeutic Patents 25:4, pages 425-441.
Read now
Read now
Haley Smith. (2013) An approach to product selection for insomnia. South African Family Practice 55:5, pages 431-433.
Read now
Read now
Octavian C Ioachimescu & Ali A El-Solh. (2012) Pharmacotherapy of insomnia. Expert Opinion on Pharmacotherapy 13:9, pages 1243-1260.
Read now
Read now
Regina M Carney & Richard C Shelton. (2011) Agomelatine for the treatment of major depressive disorder. Expert Opinion on Pharmacotherapy 12:15, pages 2411-2419.
Read now
Read now
D Alan Lankford. (2011) Tasimelteon for insomnia. Expert Opinion on Investigational Drugs 20:7, pages 987-993.
Read now
Read now
Marco Mor, Silvia Rivara, Daniele Pala, Annalida Bedini, Gilberto Spadoni & Giorgio Tarzia. (2010) Recent advances in the development of melatonin MT1 and MT2 receptor agonists. Expert Opinion on Therapeutic Patents 20:8, pages 1059-1077.
Read now
Read now
Articles from other publishers (35)
Salvador Pastor-Idoate, Milagros Mateos-Olivares, Eva María Sobas, Miguel Marcos, Alfredo Toribio, José Carlos Pastor & Ricardo Usategui Martín. (2023) Short-Wavelength Light–Blocking Filters and Oral Melatonin Administration in Patients With Retinitis Pigmentosa: Protocol for a Randomized Controlled Trial. JMIR Research Protocols 12, pages e49196.
Crossref
Crossref
Jingling Zou, Jia Yang, Biyue Chen, Jikuan Jiang, Jingyuan Liu, Cong Wang, Juan Yu, Qinghua Peng, Jun Zeng, Lusi Zhang & Bing Jiang. (2023) Melatonin protects against NMDA-induced retinal ganglion cell injury by regulating the microglia-TNFα-RGC p38 MAPK pathway. International Immunopharmacology 118, pages 109976.
Crossref
Crossref
Bojan Lalovic, Ishani Savant Landry, Margaret Moline, Larisa Reyderman & Ziad Hussein. (2023) Exposure–Response Analyses of Polysomnography and Subjective Sleep Efficacy End Points From the Phase 3 Trials of Lemborexant, a Dual Orexin Receptor Antagonist for the Treatment of Insomnia. The Journal of Clinical Pharmacology 63:4, pages 498-511.
Crossref
Crossref
Alejandro A. Ríos-Chelén, Jennifer N. Phillips, Gail L. Patricelli & Davide M. Dominoni. (2022) Editorial: Effects of Artificial Light at Night on Organisms: From Mechanisms to Function. Frontiers in Ecology and Evolution 10.
Crossref
Crossref
Marco Tetsuya Nakamura-Garcia & Alejandro Ariel Ríos-Chelén. (2021) More than noise: light, moon phase, and singing behavior in a passerine. Urban Ecosystems 25:1, pages 291-303.
Crossref
Crossref
Nurhayat ATASOY. (2019) Melatonin ve Antioksidan Etkileri. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 9:3, pages 196-201.
Crossref
Crossref
Tahir Muhammad, Tahir Ali, Muhammad Ikram, Amjad Khan, Sayed Ibrar Alam & Myeong Ok Kim. (2018) Melatonin Rescue Oxidative Stress-Mediated Neuroinflammation/ Neurodegeneration and Memory Impairment in Scopolamine-Induced Amnesia Mice Model. Journal of Neuroimmune Pharmacology 14:2, pages 278-294.
Crossref
Crossref
SHELDON H. PRESKORN. (2017) CNS Drug Development, Lessons Learned, Part 4: The Role of Brain Circuitry and Genes—Tasimelteon as an Example. Journal of Psychiatric Practice 23:6, pages 425-430.
Crossref
Crossref
Wenjing Zhang, Pengfei Jiang, Jin Chen, Chaonan Zhu, Zhengwei Mao & Changyou Gao. (2017) Application of melatonin-loaded poly(N-isopropylacrylamide) hydrogel particles to reduce the toxicity of airborne pollutes to RAW264.7 cells. Journal of Colloid and Interface Science 490, pages 181-189.
Crossref
Crossref
P. Pévet. 2017. Reference Module in Neuroscience and Biobehavioral Psychology. Reference Module in Neuroscience and Biobehavioral Psychology.
Emily Badin, Cynthia Haddad & Jess Parker Shatkin. (2016) Insomnia: the Sleeping Giant of Pediatric Public Health. Current Psychiatry Reports 18:5.
Crossref
Crossref
Charmane Eastman. (2015) Entraining the free-running circadian clocks of blind people. The Lancet 386:10005, pages 1713-1714.
Crossref
Crossref
Steven W Lockley, Marlene A Dressman, Louis Licamele, Changfu Xiao, Dennis M Fisher, Erin E Flynn-Evans, Joseph T Hull, Rosarelis Torres, Christian Lavedan & Mihael H Polymeropoulos. (2015) Tasimelteon for non-24-hour sleep–wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials. The Lancet 386:10005, pages 1754-1764.
Crossref
Crossref
Yan Ma, Ming Dong, Carol Mita, Shuchen Sun, Chung-Kang Peng & Albert C. Yang. (2015) Publication analysis on insomnia: how much has been done in the past two decades?. Sleep Medicine 16:7, pages 820-826.
Crossref
Crossref
Yan-li Huang, Xue-bing Liang, Li-qi Qian, Chuan Cai, Jun Guo, Chao Gao, Jian-hua Guan & Guo-ping Zhao. (2014) Effects of Kaixin Powder (开心散) on melatonin receptor expression and 125I-Mel binding affinity in a rat model of depression. Chinese Journal of Integrative Medicine 21:7, pages 507-515.
Crossref
Crossref
Daniel J. Buysse, Adriane Soehner, Sabra Abbott, Vishesh K. Kapur, Mark W. Mahowald, Kathy P. Parker, Edith F. Honeycutt, Susan Redline, Carlos H. Schenck & Phyllis C. Zee. 2015. Psychiatry. Psychiatry
1264
1310
.
Gaia Favero, Luigi Fabrizio Rodella, Russel J. Reiter & Rita Rezzani. (2014) Melatonin and its atheroprotective effects: A review. Molecular and Cellular Endocrinology 382:2, pages 926-937.
Crossref
Crossref
Cheng-long Xie, Yong Gu, Wen-Wen Wang, Lin Lu, Deng-lei Fu, Ai-ju Liu, Hui-qin Li, Ji-huang Li, Yan Lin, Wen-jie Tang & Guo-qing Zheng. (2013) Efficacy and safety of Suanzaoren decoction for primary insomnia: a systematic review of randomized controlled trials. BMC Complementary and Alternative Medicine 13:1.
Crossref
Crossref
Delwyn J BartlettSarah N BiggsStuart M Armstrong. (2013) Circadian rhythm disorders among adolescents: assessment and treatment options. Medical Journal of Australia 199:S8.
Crossref
Crossref
Jeremy A. Weingarten & Nancy A. Collop. (2013) Air Travel. Chest 144:4, pages 1394-1401.
Crossref
Crossref
Nina Margaret Dambrosio & Polly Mazanec. (2013) “Nurse, I Can’t Sleep!”. Journal of Hospice & Palliative Nursing 15:5, pages 267-275.
Crossref
Crossref
John E. Morley. (2013) Scientific overview of hormone treatment used for rejuvenation. Fertility and Sterility 99:7, pages 1807-1813.
Crossref
Crossref
P. Pévet. 2013. Encyclopedia of Sleep. Encyclopedia of Sleep
442
445
.
Glyn Howatson, Phillip G. Bell, Jamie Tallent, Benita Middleton, Malachy P. McHugh & Jason Ellis. (2011) Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality. European Journal of Nutrition 51:8, pages 909-916.
Crossref
Crossref
Paolo Bettica, Lisa Squassante, Stefano Zamuner, Gianluca Nucci, Heidi Danker-Hopfe & Emiliangelo Ratti. (2012) The Orexin Antagonist SB-649868 Promotes and Maintains Sleep in Men with Primary Insomnia. Sleep 35:8, pages 1097-1104.
Crossref
Crossref
Gang Wang, Clifford E. Harpole, Amit K. Trivedi & Vincent M. Cassone. (2012) Circadian Regulation of Bird Song, Call, and Locomotor Behavior by Pineal Melatonin in the Zebra Finch. Journal of Biological Rhythms 27:2, pages 145-155.
Crossref
Crossref
Sergio A. Rosales‐Corral, Dario Acuña‐Castroviejo, Ana Coto‐Montes, Jose A. Boga, Lucien C. Manchester, Lorena Fuentes‐Broto, Ahmet Korkmaz, Shuran Ma, Dun‐ Xian Tan & Russel J. Reiter. (2011) Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin. Journal of Pineal Research 52:2, pages 167-202.
Crossref
Crossref
Charles M Morin & Ruth Benca. (2012) Chronic insomnia. The Lancet 379:9821, pages 1129-1141.
Crossref
Crossref
Woong June Park. (2011) Melatonin as an Endogenous Plant Regulatory Signal: Debates and Perspectives. Journal of Plant Biology 54:3, pages 143-149.
Crossref
Crossref
Michael Spaeth, Maurizio Rizzi & Piercarlo Sarzi-Puttini. (2011) Fibromyalgia and Sleep. Best Practice & Research Clinical Rheumatology 25:2, pages 227-239.
Crossref
Crossref
Lucrecia Regina G. Romeu, Eduardo Leme A. da Motta, Carla C. Maganhin, Celina T.F. Oshima, Marcelle C. Fonseca, Karina F. Barrueco, Ricardo S. Simões, Renata Pellegrino, Edmund C. Baracat & José M. Soares-Junior. (2011) Effects of melatonin on histomorphology and on the expression of steroid receptors, VEGF, and PCNA in ovaries of pinealectomized female rats. Fertility and Sterility 95:4, pages 1379-1384.
Crossref
Crossref
Yeo-Jae Kim, Young-Ha Yoon & Woong-June Park. (2011) Supply of Tryptophan and Tryptamine Influenced the Formation of Melatonin in Viola Plants. Journal of Life Science 21:2, pages 328-333.
Crossref
Crossref
Venkatramanujam Srinivasan, Charanjit Kaur, Seithikurippu Pandi-Perumal, Gregory M. Brown & Daniel P. Cardinali. (2011) Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value. International Journal of Alzheimer's Disease 2011, pages 1-15.
Crossref
Crossref
S. Schwarz, L. Frölich & M. Deuschle. (2010) Schlafstörungen bei älteren MenschenInsomnia in the elderly: an under-diagnosed and over-treated syndrome. Der Internist 51:7, pages 914-922.
Crossref
Crossref
Christian Cajochen, Sarah Chellappa & Christina Schmidt. 2010. Science of Awakening. Science of Awakening
57
90
.